Evaluating Optimal Perioperative Pain Management: A Randomized Trial of Laparoscopic Transversus Abdominis Plane Block with Local Anesthetic, LapTAP Alone, and Local Anesthetic Alone in Minimally Invasive Oncologic Surgery

What this Trial Is About

Researchers are evaluating the effectiveness of three different routine pain management methods used during minimally invasive cancer surgery. This study compares Laparoscopic Transversus Abdominis Plane block (LapTAP) combined with Local Anesthetic (LA), LapTAP alone, and LA alone. The trial aims to improve postoperative pain control in patients undergoing various types of minimally invasive oncologic surgeries by assessing these methods in a prospective, randomized control trial. Participants will be randomly assigned to one of three groups: receiving LapTAP with LA, LapTAP alone, or LA alone during their surgery. The LapTAP procedure involves injecting ropivacaine into the fascial plane between abdominal muscles, while LA is administered around surgical port sites. All patients will receive standard pre- and post-operative care according to clinical guidelines, with the study treatments given during the surgery. During the study, researchers will collect data from medical records for 24 hours post-surgery and until hospital discharge, typically about one week. They will monitor pain scores hourly for 24 hours and at discharge, opioid consumption, recovery analgesic time, side effects, and patient satisfaction with pain management. Participation ends at hospital discharge, with no additional long-term follow-up beyond this period.

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery